Lung Cancer

Valuing Life – Medicines Access Summit

Valuing Life – Medicines Access Summit held at The Grand Hall in the Parliament Buildings, hosted by Hon David Seymour, Associate Minister of Health. Lung Foundation New Zealand is participating in the summit and we acknowledge Patient Voice Aotearoa and Medicines NZ for organising this important event. Click to view the programme

An urgent call to arms for political action on cancer

A coalition of New Zealand’s leading cancer charities, CANGO (Cancer Non-Governmental Organisations) has issued an urgent call to our political parties ahead of the election, to take action on cancer. Cancer remains New Zealand’s single biggest cause of deathand 75,000 Kiwis will be diagnosed with it during the next term of government. Although great strides […]

Proposal to fund immunotherapy for stage 4 lung cancer is a GIANT step forward

“This funding proposal meets the greatest treatment need right now with the gold standard for lung cancer and it will be life changing for stage 4 non-small cell lung cancer patients (approx. 1200 per year).” “We are ever grateful to the huge number of brave patients and their family’s who have added impact to our […]

November is Lung Cancer Awareness Month!

  Help Raise Awareness about The Symptoms of Lung Cancer by sharing our BREATHE poster LFNZ-BREATHE-Symptoms-Poster Help raise awareness about Lung Cancer Risk Factors by sharing our Risk Factors poster Risk If you or someone you care about has been diagnosed with lung cancer, please view and share our patient introductory letter. We are here […]

Questions to ask your lung cancer specialist

If you or someone you care about has been diagnosed with lung cancer, Lung Foundation New Zealand (LFNZ) is here to support you. Here are some examples of questions patients (and carers) might want to ask their specialist; Q. Can we make arrangements to have my tumour tested using comprehensive genomic testing to inform my treatment? […]

Pharmac funds immunotherapy drug Durvalumab for Lung Cancer

Pharmac is now funding a new immunotherapy medicine called durvalumab (Imfinzi) which could be life-changing for the 300 patients diagnosed with Stage 3 non-small cell lung cancer every year in New Zealand. Durvalumab is the first immunotherapy drug to be funded for lung cancer in New Zealand and it has the potential to control cancer beyond […]

Cancer Non-Governmental Organisations (CANGO)

A meeting of Cancer Non-Governmental Organisations (CANGO) was hosted by CANGO, chairman; Peter Fergusson (CEO of Leukaemia & Blood Cancer NZ) on Monday 1st August 2022 (in person and online). Lung Foundation New Zealand is an active member of CANGO. Members collaborate on key issues facing the sector and through advocacy to improve the cancer […]

World Lung Cancer Day, 1st August 2022

Lung Foundation New Zealand observed World Lung Cancer Day to honour and unite all kiwis that have been affected by New Zealand’s Biggest Cancer Killer. The purpose of World Lung Cancer Day is to raise awareness about lung cancer and its global impact, to inform and educate an understanding of lung cancer risks and the […]

Pharmac issue RFP for immunotherapy

We are pleased to finally see a RFP for lung cancer immunotherapy issued. When immunotherapy treatment is funded for stage four lung cancer (NSCLC), it will be life changing for approximately 26 patients every week.. The combined voice of; patients, carers, patients family’s, health care professionals, specialists, researchers, advocates and community has made this possible. […]

Lung Foundation at the NZ Lung Cancer Conference

Lung Foundation New Zealand representatives; Chief Executive, Philip Hope and Assoc Prof of Oncology, Chris Atkinson attended and presented at the NZ Lung Cancer Conference. 2022 July – NZ Lung Cancer Conference Click to view the conference programme.